Gara Jalqabaatti › Myeloma Baay’ee › California › Santa Monica
Qorannoo klinikaalii Myeloma Baay’ee Santa Monica, CA keessatti
Qorannoo 8 Myeloma Baay’ee f Santa Monica fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · Miili 6 fagaatti
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · Miili 6 fagaatti
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Namoota walitti qabaa jiraSadarkaa 3
- Beverly Hills Cancer Center, Beverly Hills · Miili 6 fagaatti
- Clinical Research Advisors (Encino Satellite Location), Encino · Miili 10 fagaatti
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · Miili 6 fagaatti
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Beverly Hills · Miili 6 fagaatti
Qorannoo Myeloma Baay’ee magaalota biroo keessatti
- New York City, NYQorannoo 60
- Boston, MAQorannoo 42
- Atlanta, GAQorannoo 42
- Houston, TXQorannoo 38
- Durham, NCQorannoo 37
- Nashville, TNQorannoo 32
- Denver, COQorannoo 27
- Rochester, MNQorannoo 24
- St. Louis, MOQorannoo 24
- Columbus, OHQorannoo 24
- Baldwin Park, CAQorannoo 23
- Edison, NJQorannoo 22
Qorannoo biroo Santa Monica keessatti
- Kansara Qara'a Non-Small CellQorannoo 45
- Saree OljooQorannoo 28
- Kansarii ColorectalQorannoo 23
- Saree (Gosoota Hunda)Qorannoo 22
- Kansara MetastatikiiQorannoo 19
- Dhibee QaraQorannoo 15
- Kansarii OvariiQorannoo 15
- Kansarii ProstateQorannoo 15
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 13
- Cufama OnneeQorannoo 11
- Kansa EndometiriyaaliiQorannoo 10
- Kanisa HarkaaQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.